Talphera, Inc. (TLPH)
$1.08+0.00%Close
SELLCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $22M
- Beta
- 0.68
- P/E (TTM)
- -3.48
- Short % float
- 5.65%
- Days to cover
- 6.3
- SI change
- +3.0%
- 1W
- -4.42%
- 1M
- -12.90%
- vs SPY 1W
- -5.59%
- vs SPY 1M
- -15.90%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on TLPH?
- LOPJLB’s latest quantitative signal on Talphera, Inc. (TLPH) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TLPH in?
- Talphera, Inc. (TLPH) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Talphera, Inc. (TLPH) do?
- Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimental candidate is Niyad, a lyophilized (freeze-dried) formulation of nafamostat. This anticoagulant is currently being assessed under an investigational device exemption for its application in extraco…